about
Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickaseLentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming.PCR-based quantification of amplified RNA from laser microdissected mouse liver samples.Laser secondary neutral mass spectrometry for copper detection in micro-scale biopsies.Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells.Selection-independent generation of gene knockout mouse embryonic stem cells using zinc-finger nucleases.Efficient derivation of pluripotent stem cells from siRNA-mediated Cdx2-deficient mouse embryos.Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model.Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34(pos) Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction.Generation of integration-free induced hepatocyte-like cells from mouse fibroblastsThe role of stem cells in physiology, pathophysiology, and therapy of the liver.Stem cells in liver regeneration and therapy.Sustained knockdown of a disease-causing gene in patient-specific induced pluripotent stem cells using lentiviral vector-based gene therapy.Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside?Prospects and challenges of reprogrammed cells in hematology and oncology.Concise review: cell therapies for hereditary metabolic liver diseases-concepts, clinical results, and future developments.Bronchoalveolar sublineage specification of pluripotent stem cells: effect of dexamethasone plus cAMP-elevating agents and keratinocyte growth factor.Improved retroviral episome transfer of transcription factors enables sustained cell fate modification.Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy.MicroRNA-150-regulated vectors allow lymphocyte-sparing transgene expression in hematopoietic gene therapy.Keratinocyte growth factor and dexamethasone plus elevated cAMP levels synergistically support pluripotent stem cell differentiation into alveolar epithelial type II cells.Hepatic differentiation of pluripotent stem cells.Absence of OCT4 expression in somatic tumor cell lines.A Scalable Approach for the Generation of Human Pluripotent Stem Cell-Derived Hepatic Organoids with Sensitive Hepatotoxicity Features.MicroRNA-125b-5p mimic inhibits acute liver failure.Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis.Expression of the apical conjugate export pump, Mrp2, in the polarized hepatoma cell line, WIF-B.Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells.Kindlin-2 Modulates the Survival, Differentiation, and Migration of Induced Pluripotent Cell-Derived Mesenchymal Stromal CellsEfficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.MicroRNA-199a-5p inhibition enhances the liver repopulation ability of human embryonic stem cell-derived hepatic cells.Improved generation of patient-specific induced pluripotent stem cells using a chemically-defined and matrigel-based approach.Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis.From skin to blood: a new member joins the iClub.Severe hearing loss after liver transplantation.A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation.MicroRNA-29 impairs the early phase of reprogramming process by targeting active DNA demethylation enzymes and Wnt signaling.In vitro modelling of familial amyloidotic polyneuropathy allows quantitative detection of transthyretin amyloid fibril-like structures in hepatic derivatives of patient-specific induced pluripotent stem cells.Neuroinflammatory and behavioural changes in the Atp7B mutant mouse model of Wilson's disease.Small Molecules Facilitate Single Factor-Mediated Hepatic Reprogramming.
P50
Q29114083-A89C66FE-A7C1-4229-B506-6CD9D6BB211EQ30499307-A1CB3135-58C8-4D66-98FC-9070E143B292Q30955217-AFD6820D-0110-4FDB-A860-3AB78E5E97F9Q33503276-3BF4663D-253C-49A5-8115-7EEE4671D8E1Q33587018-98BD272C-F80B-48A6-954A-FCFFC2B2A03EQ34110518-9E5C075F-4006-406F-B0DF-12F7A53A3F41Q35084104-D5878401-C151-45F4-BF5E-F3724B661F08Q35637089-F9C37DEE-2FCB-470C-B238-A3585B0C4909Q35818125-5DFDF7BE-B659-4D47-B5D6-226E31E271DCQ36209829-B1752374-E494-4C24-99DD-CCAF6278F7EAQ36672267-1DF6C136-B0BD-445C-AE49-D12C569BCCA4Q36954413-53CC816F-1764-4C1B-9604-E6FD56698A1DQ37124547-135E45F2-0873-4EFC-A0A7-5C75B8FEBA37Q37353464-38E38036-E521-4326-B75E-25A41F69AE54Q38031618-C380A939-A85C-4530-B9CE-0E90212D7872Q38293985-12A8C23A-19C2-42B3-9519-5DBC45A956DBQ38947815-3510D88E-B3E4-4F28-AA9B-38F5C731D22FQ38968105-0EA043C0-1ABC-42E7-87FD-5B28404C3066Q39304391-8444A3ED-5EC9-4730-A8BB-61192E528970Q39462857-A24DE15F-8D09-4BF0-BDB8-94733BD89EF7Q39515363-9BED252B-8714-4E10-A086-0F5D1D8A2977Q39818871-F5C82271-9EFA-41BE-9546-60F53ABF0FB6Q40046194-60F09931-9B38-4F6F-9296-E44D3F5F1119Q40138621-1D7A6A88-1187-4441-991C-C8C93B13E21BQ40639545-D3EDAE84-11ED-4F38-A71B-EDA3A83F38C3Q40774591-A0F3929B-0D25-4A53-B171-8C9A293AC1CBQ40998359-212591E3-8FD6-4FCB-AD67-8562BEB604F3Q41999327-2C465C88-D6D7-494B-81E9-B85283593AD6Q42158332-DF95F5E2-1728-43FF-B15E-530ADFE9E86FQ43468688-18AE0922-8C39-4E21-9CCC-3AA16864DD75Q45232364-321CF28A-4560-4D8E-9EB6-4577F9E9B13AQ45353644-512464F4-0B67-4C5B-AC45-F4AF432222A3Q45858446-488001BA-EB67-417B-988E-31BA9871C1D5Q46143643-C0856D54-292B-4549-BF6E-9C782A7C7014Q46512897-EC6B62B3-23A5-46FD-82E9-9924FB6D296AQ46926447-B977F21D-D815-4A07-BBBE-67DC8DA1B20EQ47943739-31122BED-F1D4-48DA-804A-70C71786341CQ48096692-CAF2C3F7-8B05-47C6-B3BC-796A3EBCC3BEQ48140242-2455D463-F4EA-4BC5-997A-E3D6FAD19B97Q50515199-51814DD4-4A98-4226-9889-B8491E5704A5
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Tobias Cantz
@ast
Tobias Cantz
@en
Tobias Cantz
@es
Tobias Cantz
@nl
Tobias Cantz
@sl
type
label
Tobias Cantz
@ast
Tobias Cantz
@en
Tobias Cantz
@es
Tobias Cantz
@nl
Tobias Cantz
@sl
prefLabel
Tobias Cantz
@ast
Tobias Cantz
@en
Tobias Cantz
@es
Tobias Cantz
@nl
Tobias Cantz
@sl
P214
P227
P106
P1153
6506187503
P21
P213
0000 0000 2205 3526
P214
P227
P31
P496
0000-0002-1382-9577
P569
1972-01-01T00:00:00Z
P735
P7859
viaf-891660